Last updated: April 23, 2026
Who Supplies PHILITH’s Drug Substance and Finished Dosage?
What is “PHILITH” and what supply chain information is required?
“PHILITH” is not a globally standardized pharmaceutical product name in widely indexed international sources. Without unambiguous identification of:
- the active ingredient(s), and
- the market/strength/form (tablet, capsule, injection) tied to the name “PHILITH,”
there is no defensible way to list suppliers of the drug substance (API) or finished dosage without risking a false attribution.
Which suppliers can be listed from authoritative records?
No supplier list can be produced from the information provided. There are no reliable, citable supplier records associated to the name “PHILITH” alone (without INN/INN salt, strength, dosage form, and jurisdiction).
What supplier types matter for PHILITH?
For pharmaceutical product due diligence, supplier mapping normally separates:
- API manufacturer(s) (drug substance)
- finished dosage manufacturer(s) (drug product)
- packager/labeler (often separate)
- marketing authorization holder (MAH) who may contract manufacturing
None of these roles can be attributed to “PHILITH” based only on the product name.
Key Takeaways
- “PHILITH” alone is insufficient to identify the specific pharmaceutical product and its underlying active ingredient(s).
- A supplier list requires unambiguous product identification (active ingredient, salt form, strength, dosage form, and jurisdiction) to avoid incorrect assignments.
- No authoritative supplier mapping can be stated from the provided input.
FAQs
1) What supplier roles should be identified for a pharmaceutical product?
API manufacturer, finished dosage manufacturer, packager/labeler, and MAH.
2) Why can’t suppliers be listed from the product name only?
Because “PHILITH” does not uniquely determine the active ingredient, strength, dosage form, or authorization record, which are the keys to supplier identification.
3) What records typically contain supplier information?
Marketing authorization dossiers, regulatory labels, EPAR/SmPC equivalents, and drug listing databases that tie product identity to manufacturers.
4) Are suppliers ever different for API vs finished dosage?
Yes. API and drug product are often made by different contract manufacturers.
5) Does the MAH always manufacture the drug?
No. The MAH often outsources manufacturing to contract manufacturers.
References
[1] None.
